Chronic Hepatitis C Therapy in Liver Cirrhosis Complicated by Telaprevir-Induced DRESS

por Mousa, Omar Y. S., Khalaf, Rossa, Shannon, Rhonda L., Egwim, Chukwuma I., Zela, Scott A., Ankoma-Sey, Victor
Publicado 2014

Efficacy and Safety of 8 Weeks of Glecaprevir/Pibrentasvir in Treatment-Naïve, HCV-Infected Patients with APRI ≤ 1 in a Single-Arm, Open-Label, Multicenter Study

por Fontana, Robert J., Lens, Sabela, McPherson, Stuart, Elkhashab, Magdy, Ankoma-Sey, Victor, Bondin, Mark, dos Santos, Ana Gabriela Pires, Xue, Zhenyi, Trinh, Roger, Porcalla, Ariel, Zeuzem, Stefan
Publicado 2019

First‐line therapies for hepatitis B in the United States: A 3‐year prospective and multicenter real‐world study after approval of tenofovir alefenamide

por Pan, Calvin Q., Afdhal, Nezam H., Ankoma‐Sey, Victor, Bae, Ho, Curry, Michael P., Dieterich, Douglas, Frazier, Lynn, Frick, Andrew, Hann, Hie‐Won, Kim, W. Ray, Kwo, Paul, Milligan, Scott, Tong, Myron J., Reddy, K. Rajender
Publicado 2022